MetaCap

Edwards Lifesciences (EW) vs Pool (POOL)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Edwards Lifesciences (EW) has outperformed Pool (POOL) over the past year, gaining 19.6% versus a loss of 13.2%. Over five years, EW leads with a -7.0% price change compared with -62.8% for POOL. Edwards Lifesciences is the larger company by market cap ($58.56 billion vs $7.44 billion), about 7.9 times the size.

On valuation, Pool trades at a lower forward P/E (18.2x vs 30.1x for Edwards Lifesciences). Pool pays a dividend yielding 2.45%, while Edwards Lifesciences does not currently pay one. Edwards Lifesciences converts more of its revenue into profit, with a net margin of 17.7% versus 7.7%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

EW+19.64%POOL-13.23%
+29%-5%-39%
Nov 21, 20251 yearNov 20, 2026
EW-12.97%POOL-63.91%
+15%-31%-77%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

EW versus POOL key metrics
MetricEWPOOL
Share price$101.85$208.23
Market cap$58.56B$7.44B
1-day change-1.95%-0.70%
YTD return+19.47%-8.97%
1-year return+19.64%-13.23%
5-year return-7.00%-62.76%
P/E ratio (TTM)59.2219.10
Forward P/E30.0818.15
EPS (TTM)$1.72$10.90
Dividend yield0.00%2.45%
Annual dividend$0.00$5.10
Revenue (latest FY)$6.07B$5.29B
Revenue growth (YoY)+11.55%-0.41%
Net income (latest FY)$1.07B$406.40M
Gross margin78.01%29.73%
Operating margin20.84%10.97%
Net margin17.69%7.68%
52-week high$108.00$278.17
52-week low$74.66$152.70
Distance from 52-week high-5.69%-25.14%
Analyst consensusbuynone
Avg. price target upside+11.62%+0.53%
Average volume3.92M775.13K
Shares outstanding575.00M35.72M
Employees16,0006,000
SectorHealth CareConsumer Discretionary
IndustryIndustrial SpecialtiesIndustrial Specialties

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Edwards Lifesciences is about 7.9 times larger than Pool by market value ($58.56B vs $7.44B).
  • EW has outperformed POOL by 32.9 percentage points over the past year.
  • Edwards Lifesciences trades at a higher earnings multiple (59.2x vs 19.1x trailing P/E).
  • Pool offers a meaningfully higher dividend yield (2.45% vs 0.00%).
  • Edwards Lifesciences is more profitable, keeping 17.7 cents of every revenue dollar as net income versus 7.7 cents for Pool.
  • Edwards Lifesciences grew revenue faster in its latest fiscal year (+11.55% vs -0.41%).
  • The two companies sit in different sectors: Edwards Lifesciences in Health Care and Pool in Consumer Discretionary.

About Edwards Lifesciences

EW stock →

Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands.

Health Care · Industrial Specialties · 16,000 employees

About Pool

POOL stock →

Pool Corporation distributes swimming pool supplies, equipment, related leisure, irrigation, and landscape maintenance products in the United States and internationally. It offers maintenance products, including chemicals, supplies, and pool accessories; repair and replacement parts for pool equipment, such as cleaners, filters, heaters, pumps, and lights; and building materials, such as concrete, plumbing and electrical components, functional and decorative pool surfaces, decking materials, tiles, hardscapes, and natural stones for pool installations and remodeling.

Consumer Discretionary · Industrial Specialties · 6,000 employees

EW vs POOL FAQ

Which is bigger, Edwards Lifesciences or Pool?

Edwards Lifesciences (EW) is larger, with a market capitalization of $58.56B compared with $7.44B for Pool (POOL).

Which stock has performed better over the past year, EW or POOL?

EW returned +19.64% over the past 12 months, compared with -13.23% for POOL (price return, excluding dividends). Past performance does not predict future results.

Which has the lower P/E ratio, EW or POOL?

POOL has the lower trailing P/E at 19.1, versus 59.2 for EW. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.

Which pays a higher dividend, Edwards Lifesciences or Pool?

Pool pays a dividend yielding 2.45%, while Edwards Lifesciences does not currently pay a regular dividend.

Are Edwards Lifesciences and Pool in the same industry?

Yes. Both are classified in the Industrial Specialties industry within the Health Care sector.

More comparisons